Chinese scientists have developed an innovative electronic comb that restored nearly 98 per cent hair coverage in mice within 28 days, offering a promising new approach to treating pattern hair loss.
The experimental device, named “Detangle,” was developed by researchers from Beihang University in collaboration with scientists from City University of Hong Kong and other institutions.
According to a study published in the scientific journal Nature Communications on November 3, 2026, the comb combines electrical stimulation with targeted delivery of therapeutic molecules to hair follicles.
How Does the Electric Comb Work?
The device features specially designed teeth containing electrodes of different heights and integrated drug-delivery modules.
When the comb moves across the skin, it generates short electrical pulses that stimulate hair follicles and help deliver therapeutic molecules deeper into the skin.
The treatment uses two experimental therapies:
- VEGFA plasmid: Designed to promote the formation of blood vessels around hair follicles, potentially improving their blood supply.
- SRD5A2 siRNA: Designed to suppress an enzyme involved in the production of dihydrotestosterone (DHT), a hormone associated with follicle shrinkage in pattern hair loss.
The electrical stimulation also helps therapeutic molecules enter follicle cells through a process known as electroporation, which temporarily increases cell membrane permeability.
Researchers reported that the device could deliver molecules approximately 660 micrometres into the skin, nearly nine times deeper than conventional topical application.
Nearly 98% Hair Regrowth in 28 Days
During laboratory experiments, researchers tested the device on male mice with artificially induced androgenetic alopecia, a condition associated with pattern hair loss.
After 28 days, the results showed significant differences between treatment groups:
- Detangle with combined therapies: Approximately 97.85% hair coverage.
- Topical minoxidil: Approximately 70% hair coverage.
- Oral finasteride: Approximately 50% hair coverage.
- Electrical stimulation alone: Approximately 40% hair regrowth.
- Untreated mice: Approximately 1% hair regrowth.
The combined treatment was administered once every three days.
Researchers also observed improvements in hair follicle numbers, local blood circulation and indicators associated with blood vessel formation.
Safety and Future Applications
The research team reported no obvious abnormalities in the skin, inflammatory responses or nerve-related indicators examined during the experiments.
The findings suggest that combining electrical stimulation with targeted drug delivery could offer a new approach to treating androgenetic alopecia.
However, the technology has so far been tested only in mice. Its effectiveness, long-term safety and potential side effects in humans remain unknown.
Researchers have not announced a confirmed timeline for human clinical trials or commercial availability.
A Potential New Direction for Hair Loss Treatment
The development could open new possibilities for treating hair loss by combining wearable bioelectronic technology with targeted delivery of therapeutic molecules.
If future human studies demonstrate similar results, the Detangle system could eventually become an additional option for people experiencing pattern hair loss.
For now, scientists say further research is needed before the experimental device can be considered a treatment for human hair loss.
